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Abstract
Background: Cerebral microvascular abnormality is frequently associated with lacunar and subcortical ischemic
lesions. We performed acute and follow-up CT perfusion scans over the first 3 months after ischemic stroke to
investigate disturbances of the blood–brain barrier (BBB) and cerebral perfusion in patients with lacunar/subcortical
lesions compared to those with cortical lesions alone.
Methods: Thirty-one patients with lacunar/subcortical infarct (n = 14) or with cortical large vessel infarct (n = 17)
were recruited and underwent a CT perfusion study at admission, 24 h, 7 days and 3 months after stroke using a
two-phase imaging protocol. Functional maps of BBB permeability surface area product (BBB-PS), cerebral blood
flow (CBF) and blood volume (CBV) at follow-up were co-registered with those at admission, and the measurements in
non-infarcted ipsilateral basal ganglia and thalamus were compared within each group and between the two groups.
Results: For the lacunar/subcortical group, BBB-PS within non-infarcted ipsilateral basal ganglia and thalamus peaked
at day 7 compared to all other time points, and was significantly higher than the cortical group at day 7 and month 3.
The CBF and CBV in the same region were significantly lower at admission and transient hyperemia was seen at day 7
in the lacunar/subcortical group.
Conclusion: Disturbed BBB-PS and compromised cerebral perfusion over the first 3 months post stroke were shown in
the non-infarcted basal ganglia and thalamus of lacunar/subcortical stroke using CT perfusion. Future studies are
required to elucidate the relationship of post-stroke BBB disturbances to chronic cognitive impairment.
Keywords: Blood–brain barrier, Cerebral blood flow, Lacunar/subcortical infarct, CT perfusion, Cerebral small vessel
disease
Background
Stroke is one of the leading causes of death and long-
term disability [1]. It is also an important contributing
factor to cognitive dysfunction or dementia post stroke,
including vascular cognitive impairment (VCI) [2].
Around 15–25 % of ischemic strokes are lacunar strokes
[3], which can manifest as lacunes or subcortical lesions
on routine MR and CT images. Recent clinical evidence
has suggested that lacunar and subcortical lesion might
exert adverse effects on cognition and memory [3–5].
Studies have shown that the blood–brain barrier (BBB)
becomes more permeable in VCI patients with subcor-
tical lesions and leukoaraiosis [6–8]. Contrast-enhanced
MRI reveals that BBB permeability increases in patients
with lacunar lesions, compared to normal control or cor-
tical stroke [7–10]. Moreover, pathological studies report
increased level of cerebrospinal fluid (CSF) albumin in
patients with lacunar/subcortical lesion or white matter
disease [3, 6]. Clinically, the primary types of brain lesion
in cerebral small vessel-related VCI are lacunar and
subcortical lesions, which are caused by ischemia due to
arteriolar occlusion (e.g. lenticulostriate arteries, recurrent
artery of Heubner and thalamoperforating arteries). The
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anatomic regions corresponding to these vascular territor-
ies are basal ganglia, thalamus and surrounding white
matter (involved in motor movement, cognition, learning,
visual memory and signal processing) [11, 12]. The ische-
mic event/occlusion may play as a trigger for the BBB ab-
normality in the presence of cerebral small vessel disease.
Together, the evidence suggests that there is an underlying
association between lacunar/subcortical ischemic stroke
and cerebral microvascular abnormality, thus longitudinal
investigation of subcortical BBB permeability may better
demonstrate BBB leakage and microvascular dysfunction
in stroke patients with small subcortical ischemic lesions
before progressing to VCI. The chronic BBB leakage may
act as a contributor and predictor for long-term cognitive
impairment and associated pathology.
Recently, CT perfusion (CTP), a physiologic imaging
modality requiring intravenous injection of iodinated
contrast agent to image blood flow and associated
hemodynamic parameters [13], is used for diagnosis of
acute ischemic stroke and vasospasm. CTP not only
measures tissue perfusion but also vascular permeability
surface product (PS), an indicator of BBB integrity and
permeability [13, 14]. Current CTP technique is more
accessible and faster to perform in clinical practice than
MRI and xenon-perfusion CT [15], and is ideal for stud-
ies at acute and subacute stages of stroke.
In this study we sought to examine the time course of
BBB permeability changes measured with CTP in pa-
tients from the acute phase to 3 months post stroke to
determine whether BBB permeability of the non-infarcted
ipsilateral basal ganglia and thalamus is different in pa-
tients with and without lacunar/subcortical lesion.
Methods
Subjects
Patients with clinically diagnosed acute ischemic stroke
were consecutively and prospectively recruited from
February 2009 to July 2011 at one institution. All pa-
tients were admitted to the Department of Neuroscience
of the University of Ferrara within 6 h of stroke symp-
tom onset. Patients with impaired renal function, con-
traindications to iodinated contrast agent, intracerebral
hemorrhage at admission, brain stem infarct, previous
stroke with clear deficits, missing CTP imaging at ad-
mission or any follow-up time points (24 h, 7 days and
3 months), severe motion artifacts in CTP imaging,
pregnancy and age < 18 years were excluded. For this
study, thirty-one patients who underwent non-enhanced
CT (NECT) and two-phase CTP acquisition (2.5 min) at
admission and all follow-up exams were included. The
study was approved by the Committee for Medical Ethics
in Research of the University of Ferrara and informed con-
sent was obtained from all patients enrolled in the study.
All patients were diagnosed by an experienced neur-
ologist (G.R.) who evaluated the clinical stroke symp-
toms at admission based on the National Institutes of
Health Stroke Scale (NIHSS) [16]. Clinical outcome was
assessed using the modified Rankin scale (mRS) at 3-
month post stroke [17] and mRS ≤ 2 and > 2 were de-
fined as good and poor outcome, respectively. Patients
having lacunar/subcortical lesion (≤20 mm in diameter)
on month-3 NECT images were separated from those
without subcortical lesion (i.e. large vessel infarcts pri-
marily in the cortical gray matter). Vascular risk factors
including hypertension, diabetes, previous silent infarct,
ischemic heart disease and thrombolytic treatment were
documented.
CT perfusion acquisition protocol and functional maps
CTP studies were performed at admission, 24 h, 7 days
and 3 months post stroke. Prior to CTP scan, a NECT
scan was performed to locate hypodense ischemic lesion.
Each CTP scan started with an intravenous injection of
50 mL of iodinated contrast agent (Iomeron 300 mg/ml,
Bracco Imaging SpA, Milan, Italy) at the rate of 4 mL/s,
followed by 45 mL of saline flush at the same infusion
rate. A 20-gauge catheter and cephalic vein were used in
peripheral venous access for contrast injection. Each
CTP acquisition used a two-phase protocol: eight 5 mm-
thick slices covering a 40 mm section of the brain were
scanned continuously for 45 s with images reconstructed
at 0.5 s intervals and then scanned once every 15 s for
another 105 s for a total acquisition time of 2.5 min.
The scan parameters for both phases were 25 cm FOV,
80 kV, 100 mA, and 1 s per gantry rotation. BBB
permeability-surface (BBB-PS), cerebral blood flow
(CBF) and cerebral blood volume (CBV) maps were
generated with the delay insensitive CT Perfusion soft-
ware based on the modified Johnson-Wilson model
(GE Healthcare, Waukesha, WI) [18, 19].
Image registration and analysis
CTP maps from all follow-up time points and NECT at
3 month of each patient were manually co-registered
with the admission maps using Analyze v11.0 software
(Mayo Clinic, Rochester, MN). The averages of the
source CTP images were used as references for each
registration. For lacunar/subcortical stroke, regions of
interest (ROIs) were defined in the ipsilateral and contra-
lateral basal ganglia (caudate nucleus, putamen, globus
pallidus) and thalamus as well as the infarct using the
month-3 NECT (Fig. 1). Data from the ipsilateral deep
gray nuclei excluding the infarct were normalized with
contralateral data to obtain relative CBF (rCBF), CBV
(rCBV) and BBB-PS (rBBB-PS) for each time point. The
same analysis was used for the cortical stroke group,
except that no region of deep gray nuclei was excluded.
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Statistical methods
Statistical analyses were performed using SigmaPlot
v12.0 (Systat Software, San Jose, CA). The unpaired t-
test was used for comparisons of NIHSS score at admis-
sion, mRS at month 3 and age between patients with
and without lacunar/subcortical lesion. Fisher’s exact test
was used for demographic data between the two groups.
Relative CBF, CBV and BBB-PS in the non-infarcted ipsi-
lateral deep gray nuclei were compared between the two
groups, and also between the time points within each
group using two-way ANOVA with group and time as
independent factors. Tukey’s post hoc test was then used
for inter-group comparison. Statistical significance was
set at p < 0.05. All CTP-derived data were presented as
mean ± SEM.
Results
The 31 patients (18 F, 13 M) included in this study were
divided into two groups, 14 patients with lacunar/sub-
cortical infarct and 17 patients with cortical stroke based
on month-3 NECT images. Mean proportion of the
infarcted area in the basal ganglia or thalamus for the
lacunar/subcortical group was small, 11.4 ± 3.6 %. There
were no significant differences in mean age, gender,
hypertension and previous silent infarct between the two
groups (Table 1). The proportion of the patients who
received intravenous thrombolysis was lower but not
significant in the lacunar/subcortical group (Table 1).
The mean NIHSS at admission and mRS at 3 months
post stroke were not significantly different between the
two groups (Table 1).
Mean rBBB-PS (Fig. 2) in the non-infarcted ipsilateral
basal ganglia and thalamus (deep gray nuclei) in the la-
cunar/subcortical group was significantly higher at day 7
and month 3 (p < 0.01 at day 7 and p < 0.05 at month 3),
and non-significantly higher at admission and 24 h than
the cortical group. Particularly, at day 7 the lacunar/sub-
cortical group showed the largest difference in rBBB-PS
from the cortical group (2.78 ± 0.64 vs 1.07 ± 0.06). In
addition, intra-group comparisons showed that the
rBBB-PS within the lacunar/subcortical group at day 7
was significantly higher than those at all other time
points (p < 0.05). This intra-group difference was not
seen in the cortical patients. An example of increased
BBB permeability was shown by the enhanced signal in
BBB-PS maps (Fig. 1) in the right basal ganglia (puta-
men) where the contrast agent leaked into the interstitial
space of brain tissue through a compromised BBB.
Mean rCBF in the non-infarcted ipsilateral basal gan-
glia and thalamus (Fig. 3a) was significantly lower in
patients with lacunar/subcortical lesions at admission,
0.72 ± 0.05, as compared to the cortical group, 0.86 ± 0.03
(p < 0.01). Similarly, mean rCBV in the non-infarcted ipsi-
lateral basal ganglia and thalamus (Fig. 3b) in the lacunar/
subcortical group was significantly lower than the cortical
group at admission (0.80 ± 0.05 vs 0.92 ± 0.03, p < 0.05).
There were no significant differences in both rCBF and
rCBV at 24 h, day 7 and month 3 between the two
groups, although at day 7 rCBF and rCBV were slightly
higher in the lacunar/subcortical group.
Discussion
In this study, CTP imaging revealed that patients with
lacunar/subcortical lesions had significantly higher BBB-
PS in the non-infarcted basal ganglia and thalamus at
day 7 and month 3 than patients with cortical stroke.
This finding is consistent with previous MRI evidence of
increased BBB-PS in lacunar stroke and VCI with sub-
cortical ischemic lesions [6–10, 20]. In addition to BBB-
Fig. 1 BBB-PS maps in a patient with a subcortical infarct in right
putamen (as shown on the 3-month NECT). The maps from acute
phase to 3 months after stroke were shown. Focally elevated BBB-PS
was observed in right putamen at 24 h, day 7 and month 3 for the
patient. Caudate nucleus, putamen, globus pallidus and thalamus in
both ipsilateral and contralateral hemisphere were outlined in red.
The infarct in the right putamen shown on the 3-month NECT was
also outlined in red (smaller ROI within the right putamen)
Table 1 Characteristics of patients with and without
lacunar/subcortical lesion
Clinical data Subcortical/lacunar Cortical p value
(n = 14) (n = 17)
Agea 71 ± 10 69 ± 12 0.50
Female n (%) 9 (64 %) 9 (53 %) 0.72
Hypertension n (%) 9 (64 %) 12 (71 %) 1.00
Previous silent infarct n (%) 5 (36 %) 7 (41 %) 1.00
Thrombolysis n (%) 10 (71 %) 14 (82 %) 0.67
NIHSS at admissiona 15.1 ± 6.2 12.3 ± 6.2 0.21
mRs at month 3a 2.1 ± 1.1 2.2 ± 1.5 0.83
aAge, NIHSS and mRS are represented as mean ± SD
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PS, at acute phase (admission) CBF and CBV within
non-infarcted ipsilateral basal ganglia and thalamus in
the lacunar/subcortical patients were significantly lower
than the cortical group, suggesting an ischemic influence
in the subcortical region.
Lacunar and subcortical lesions, along with white mat-
ter lesions (WML), are frequently found in patients with
VCI and AD [6]. The well cited Nun study found that,
in subjects with AD pathology, the presence of subcor-
tical or lacunar infarcts (in the basal ganglia, thalamus
and deep white matter) at autopsy was associated with a
20-fold higher risk to develop dementia compared to
those without subcortical infarcts [21]. Therefore, it is
important to understand the pathogenesis of lacunar/
subcortical lesion. Some studies report that hypoperfu-
sion (reduced CBF) was found in leukoaraiosis, which is
frequently related to cerebral microvascular disturbances
in lacunar/subcortical stroke [22, 23]. In our study,
within the acute phase significantly reduced CBF and
CBV was present in the non-infarcted basal ganglia and
thalamus of the lacunar/subcortical patients, but not in
the cortical patients, indicating the presence of a more
severe ischemia in the basal ganglia and thalamus of the
lacunar/subcortical group. At day 7, differences in CBF
and CBV between the two groups were not significant
but CBF and CBV were higher in the lacunar/subcortical
group. This is probably due to reactive hyperemia or
compensatory blood supply (reperfusion) from collateral
flow to the viable penumbra, similar to the results found
in animal model of cerebral ischemia [24]. This appeared
to be transient since, at month 3, slightly lower CBF and
Fig. 2 Blood–brain barrier (BBB) permeability (PS) in the non-infarcted ipsilateral basal ganglia and thalamus. rBBB-PS was significantly higher in
the lacunar/subcortical group compared to the cortical group at 7 days and 3 months after stroke (*, P < 0.01 at 7 days and P < 0.05 at 3 months).
The largest difference between the two groups occurred at day 7, with about 2.5-fold higher value in the lacunar/subcortical group than the cortical
group. In the lacunar/subcortical group, rBBB-PS remained stable between admission and 24 h but significantly increased from 24 h to 7 days post
stroke (P < 0.05), and then significantly declined at 3 months (P < 0.05). No significant intra-group differences in BBB-PS over time were seen in the
cortical group
Fig. 3 a CBF and b CBV in the non-infarcted ipsilateral basal ganglia
and thalamus. Both rCBF and rCBV in the lacunar/subcortical group
were significantly lower at admission (*, P < 0.01 for rCBF and P < 0.05
for rCBV) and remained lower at 24 h (no significance) than the cortical
group. rCBF and rCBV were higher but not significant in the lacunar/
subcortical group at day 7 compared to the cortical group. At month
3, there was no significant rCBF and rCBV difference between the
two groups
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CBV were again detected in the affected region in the
lacunar/subcortical group possibly due to compromised
vascular reactivity and tissue damage. Several studies show
that greater BBB disruption is associated with reperfusion
post cerebral ischemia in animal models [24–26]. This is
consistent with our finding that the greatest BBB dis-
ruption (the highest BBB-PS) was observed along with
the reperfusion at day 7 in lacunar/subcortical stroke.
In addition, the majority of the patients in this study
had thrombolytic treatment (tPA) at admission, which
has also been associated with increased BBB permeabil-
ity after reperfusion (as a secondary injury) in previous
studies [27, 28]. Moreover, other reports indicate that
early post-ischemia hyperperfusion may be associated
with infarction or impaired BBB at later time [29, 30],
which could explain the higher BBB-PS presented at
month 3 in the lacunar/subcortical patients.
Hypoperfusion in the basal ganglia and thalamus at
acute phase is not the only vascular abnormality of la-
cunar/subcortical lesion that is associated with cerebral
small vessel disease. Additionally, increased BBB per-
meability (i.e. leaky cerebral microvessels) could be an
underlying pathogenic mechanism that is exacerbated
by ischemia [9, 10, 20]. Pathologically, extravasation of
serum proteins such as albumin into CSF, which is an
indicator of BBB disruption, has been demonstrated in
VCI and AD patients, particularly in those with lacu-
nar/subcortical ischemic lesion or WML [6, 7, 31]. In
our study, BBB-PS in the basal ganglia and thalamus of
the lacunar/subcortical patients was significantly ele-
vated and peaked at day 7, compared to that of cortical
group. This reflects a dynamic transition of BBB abnor-
mality from acute phase to a maximum opening/disrup-
tion of BBB at subacute phase for lacunar/subcortical
lesion. At month 3, BBB-PS of the non-infarcted basal
ganglia and thalamus in the lacunar/subcortical group was
still significantly higher than in the cortical group, but at a
lower level than at day 7. This suggests that after an is-
chemic insult BBB in the viable area of the lacunar/
subcortical group remained more affected and vulner-
able than the cortical group. All these observations, to
some extent, may explain early BBB-PS changes of
cerebral microvascular disease, especially in the af-
fected subcortical regions such as basal ganglia and
thalamus, where about 31 and 12 % of lacunar infarcts
are located respectively [11]. Recent perfusion MRI
studies found significantly increased BBB permeability
in the basal ganglia, CSF and deep white matter in sub-
jects with VCI and lacunar/subcortical ischemic vessel
disease [6–10, 20], which is consistent with our find-
ings. This increased BBB permeability observed from
our and other studies posits a link between cerebral
small vessel disease and lacunar/subcortical lesions.
All of the above evidence strongly supports cerebral
microvascular dysfunction as an important contributing
vascular mechanism for lacunar/subcortical lesions.
In comparison with previous studies [8–10], the
strengths of this study include: (1) multiple time points
post stroke at acute and subacute phase over the first
3 months to better identify early changes of BBB-PS, a
biomarker of cerebral microvascular dysfunction. In
addition, we registered CTP maps for all different time
points to ensure measurements are from the same re-
gion; (2) multiple parameters such as CBF, CBV and
BBB-PS can be produced at the same time for each
CTP scan, increasing the chance to detect not only ini-
tial (acute) ischemic deficits with viable penumbra but
also BBB disturbances at acute and subacute period; (3)
in contrast to MRI, changes in CT signal intensity (at-
tenuation) are linearly related to changes in contrast
agent concentration, resulting in better measurements
of perfusion parameters in detecting defects [14, 32].
The limitations of the study are the small size of the
sample population and limited coverage of the brain
with relatively thick slices which diminished our ability
in detecting some small lacunar/subcortical lesions. The
radiation dose is another concern. In our study, no pa-
tients showed acute radiation-related complications. The
effective radiation dose in a typical CTP study is about
2 mSv (at 100–150 mA and 80 kV), which is significantly
lower than xenon-perfusion CT and SPECT [15]. With
advancement of new iterative reconstruction techniques
[33], radiation dose of a CTP study can be reduced to
fraction of the background radiation dose [34]. This
would allow repeated examinations for suspected VCI
patients with cerebral small vessel disease to monitor
BBB permeability over time.
Conclusion
This study demonstrated that with serial CTP imaging, a
more profound decrease in CBF and CBV at acute phase
and a higher BBB-PS in the non-infarcted basal ganglia
and thalamus at subacute phase and month 3 in patients
with lacunar/subcortical lesions, compared to patients
with cortical stroke. These findings suggest that ischemic
insult can exacerbate vascular abnormalities, especially
subcortical BBB permeability in the presence of cerebral
small vessel disease.
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